Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these ...

Chronic Obstructive Pulmonary Disease, or COPD, is a serious condition that affects the lungs, making it hard to breathe. It develops slowly over time and is often caused by damage to the airways and ...

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary ...

According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of ...

Patients with chronic obstructive pulmonary disease (COPD) are at an increased risk of cognitive impairment, with a notably ...

Chronic obstructive pulmonary disease (COPD) is a disease of the respiratory tract that is characterized narrowing of the small airways and destruction of lung tissue. This leads to poor airflow ...

More than 20 respiratory conditions could receive extra financial support from PIP to help with daily living costs ...

US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic obstructive pulmonary disease: London, UK Wednesday, December 11, 2024, 10:00 Hrs [IST] GSK ...

November is National Chronic Obstructive Pulmonary Disease Awareness Month. It’s time to raise awareness about lung disease within our communities. By understanding the causes, reducing our risk ...

COPD is a serious lung disease characterized by inflammation and narrowing of the airways, leading to breathing difficulties. This condition is primarily caused by long-term smoking and exposure to ...